← All trials
NCT03009864
Early Phase 1Interventional
Exploratory trials, involving very limited human exposure, with no therapeutic or diagnostic intent (e.g., screening studies, microdose studies).
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jan 1, 2017
- Primary completion
- Sep 1, 2019
- Completion date
- May 1, 2020
- First posted
- —
- Last posted
- —
- Enrollment
- 632
- Arms / groups
- 2 / —
- Source
- AACT · pre-existing
Sponsors
- China Academy of Chinese Medical SciencesLead sponsor
- Shijiazhuang City Hospital of Traditional Chinese MedicineCollaborator
- Changchun Hospital of Traditional Chinese MedicineCollaborator
- Xingtai City Hospital of Traditional Chinese MedicineCollaborator
- Medicine Zibo Wanjie Tumor HospitalCollaborator
- Zouping Country Hospital of Traditional Chinese MedicineCollaborator
- She Country Hospital of Traditional Chinese MedicineCollaborator
- Anhui Medical UniversityCollaborator
- Zhengzhou UniversityCollaborator
- Baodin City Hospital of Traditional Chinese MedicineCollaborator
- Baishi HospitalCollaborator
- Hubei University of Chinese MedicineCollaborator
- Capital Medical UniversityCollaborator
- China Academy of Chinese Medical SciencesReponsible party - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.